“…Sections were the exposed to select combinations of the following primary antibodies (in PB also containing 1% NDS and 0.2% Triton X-100 for 48 -72 h at 4°C): guinea pig anti-parvalbumin (1:300, Synaptic Systems), rabbit anti-parvalbumin (1: 2000, Swant), biotinylated rabbit anti-parvalbumin (20 g/ml; Synaptic Systems), rabbit anti-system A transporter 1 (SAT1, 1:1000) (Solbu et al, 2010), goat anti-CB 1 cannabinoid receptor (CB 1 R, 1:1000) (Kawamura et al, 2006), rabbit anti-VGLUT1 (1:2000, Synaptic Systems), guinea pig anti-VGLUT1 (1:1000) (Kaneko et al, 2002), guinea pig anti-vesicular glutamate transporter 3 (VGLUT3, 1:1000) (Hioki et al, 2004), goat anti-calretinin (1:1000; Swant), mouse anti-calbindin D28k (CB, 1:1000; Swant), rabbit anti-GABA A receptor ␣1 subunit (5 g/ml) (Fritschy et al, 1992), mouse anti-GAD67 (1:5000; Millipore Bioscience Research Reagents), rabbit antineuropeptide Y (1:400, Diasorin), rabbit anti-somatostatin (1:400, Acris), guinea pig anti-GFAP (1:400, Synaptic Systems), rabbit anti-ionized Ca 2ϩ -binding protein adaptor molecule 1 (Iba-1; 1:200, Wako) and biotinylated mouse anti-neuronal nuclei (NeuN; 20 g/ml; Millipore Bioscience Research Reagents). After extensive rinsing in PB, immunoreactivities were revealed by carbocyanine (Cy) 2, 3 or 5-tagged secondary antibodies raised in donkey [1:200 (Jackson ImmunoResearch), 2 h at 22Ϫ24°C].…”